Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)
China · Delayed Price · Currency is CNY 13.63
+0.42 (3.18%)
Jul 30, 2026, 1:45 PM CST
SHE:300534 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 234.61 | 241.33 | 310.02 | 288.95 | 369.24 | 99.12 |
Cash & Short-Term Investments | 234.61 | 241.33 | 310.02 | 288.95 | 369.24 | 99.12 |
Cash Growth | -14.64% | -22.16% | 7.29% | -21.75% | 272.52% | -16.13% |
Accounts Receivable | 292.05 | 257.51 | 223.85 | 223.8 | 220.95 | 140.44 |
Other Receivables | 6.06 | 11.06 | 26.99 | 19.5 | 19.7 | 5.53 |
Receivables | 298.11 | 268.57 | 250.83 | 243.3 | 240.65 | 145.98 |
Inventory | 109.62 | 115.99 | 115.9 | 97.4 | 85.87 | 55.7 |
Prepaid Expenses | - | 1.94 | 0.04 | 0.16 | 0.2 | 1.4 |
Other Current Assets | 42.31 | 26.46 | 36.74 | 17.19 | 31.57 | 6.51 |
Total Current Assets | 684.65 | 654.3 | 713.53 | 647 | 727.54 | 308.7 |
Property, Plant & Equipment | 527.21 | 531.64 | 519.78 | 439.42 | 333.85 | 305.21 |
Long-Term Investments | 52.75 | 52.75 | 51.36 | 54.2 | 54.2 | 54.2 |
Goodwill | 13.72 | 13.72 | 13.72 | 13.72 | 13.72 | 13.72 |
Other Intangible Assets | 67.86 | 68.65 | 63.06 | 62.07 | 62.22 | 50.74 |
Long-Term Deferred Tax Assets | 14.13 | 14.13 | 11.5 | 10.12 | 8.58 | 5.77 |
Long-Term Deferred Charges | 6.4 | 5.68 | 1.66 | 0.23 | 0.14 | - |
Other Long-Term Assets | 53.7 | 53.62 | 70.51 | 109.89 | 117.25 | 85.73 |
Total Assets | 1,420 | 1,394 | 1,445 | 1,337 | 1,318 | 824.07 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 325.39 | 319.44 | 371.29 | 243.56 | 209.01 | 32.63 |
Accrued Expenses | 6.87 | 19.19 | 27.39 | 23.11 | 58.51 | 6.3 |
Short-Term Debt | - | 0.25 | 4.9 | 30.03 | - | - |
Current Portion of Long-Term Debt | - | 25.08 | 10.2 | - | - | - |
Current Portion of Leases | - | 1.45 | 1.16 | 1.19 | - | - |
Current Income Taxes Payable | 17.23 | 7.67 | 30.91 | 21.1 | 17.48 | 1.78 |
Current Unearned Revenue | 9.14 | 15.62 | 22.4 | 65.65 | 77.24 | 12.96 |
Other Current Liabilities | 86.81 | 69.04 | 73.44 | 53.7 | 45.08 | 14.64 |
Total Current Liabilities | 445.44 | 457.74 | 541.69 | 438.34 | 407.32 | 68.32 |
Long-Term Debt | 103.35 | 103.35 | 95.84 | 109.6 | - | - |
Long-Term Leases | 2.17 | 2.38 | 2.58 | 3.72 | - | - |
Long-Term Unearned Revenue | 52.46 | 46.9 | 40.08 | 26.44 | 26.89 | 22.92 |
Long-Term Deferred Tax Liabilities | 3.05 | 3.05 | 1.54 | 0.24 | - | 0 |
Other Long-Term Liabilities | - | - | 23.75 | 46.8 | - | - |
Total Liabilities | 606.47 | 613.42 | 705.47 | 625.14 | 434.21 | 91.24 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 303.35 | 303.35 | 303.35 | 303.35 | 303.35 | 303.35 |
Additional Paid-In Capital | 97.15 | 97.15 | 92.15 | 66.68 | 324 | 231.49 |
Retained Earnings | 333.67 | 309.01 | 277.19 | 263.68 | 202.03 | 185.42 |
Comprehensive Income & Other | -1.05 | -1.05 | -2.24 | - | - | - |
Total Common Equity | 733.11 | 708.45 | 670.45 | 633.71 | 829.38 | 720.25 |
Minority Interest | 80.84 | 72.62 | 69.21 | 77.8 | 53.92 | 12.59 |
Shareholders' Equity | 813.96 | 781.08 | 739.66 | 711.51 | 883.3 | 732.84 |
Total Liabilities & Equity | 1,420 | 1,394 | 1,445 | 1,337 | 1,318 | 824.07 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 105.52 | 132.51 | 114.68 | 144.54 | - | - |
Net Cash (Debt) | 129.09 | 108.82 | 195.34 | 144.4 | 369.24 | 99.12 |
Net Cash Growth | -25.80% | -44.29% | 35.27% | -60.89% | 272.52% | 105.97% |
Net Cash Per Share | 0.43 | 0.36 | 0.64 | 0.48 | 1.22 | 0.33 |
Filing Date Shares Outstanding | 303.35 | 303.35 | 303.35 | 303.35 | 303.35 | 303.35 |
Total Common Shares Outstanding | 303.35 | 303.35 | 303.35 | 303.35 | 303.35 | 303.35 |
Working Capital | 239.21 | 196.56 | 171.84 | 208.65 | 320.22 | 240.38 |
Book Value Per Share | 2.42 | 2.34 | 2.21 | 2.09 | 2.73 | 2.37 |
Tangible Book Value | 651.53 | 626.08 | 593.66 | 557.91 | 753.43 | 655.78 |
Tangible Book Value Per Share | 2.15 | 2.06 | 1.96 | 1.84 | 2.48 | 2.16 |
Buildings | - | 524.52 | 483.38 | 339.21 | 338.42 | 283.91 |
Machinery | - | 240.33 | 205.81 | 148.61 | 125.14 | 66.35 |
Construction In Progress | - | 5.64 | 27.61 | 105.7 | 6.09 | 37.76 |